Li Wenge
Directeur Technique/Scientifique/R&D chez Chiral Quest (Suzhou) Co., Ltd.
Provenance du réseau au premier degré de Li Wenge
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Chiral Quest (Suzhou) Co., Ltd.
 Chiral Quest (Suzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chiral Quest (Suzhou) Co. Ltd. provides drug discovery services. It focuses on the development and manufacture of chiral catalysts, development of synthetic processes, and a technology applications platform. Its products include a, b, and Cyclicb-amino acids; b-hydroxy acids; chiral amines, alcohols, amino alcohols, and pyrrolidines; succinates; and achiral compounds, a-hydroxy acids, and APIs and intermediates. Chiral Quest has one manufacturing site in Jiangxi province, and three overseas offices in USA, Europe & India respectively. The company was founded by Xumu Zhang in 2000 and is headquartered in Suzhou, China.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Li Wenge via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Tongji University | College/University | Masters Business Admin | |
| Imperial College London | College/University | Doctorate Degree | |
| Babson College | College/University | Graduate Degree | |
| City University of New York | College/University | Graduate Degree | |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of St. Andrews | College/University | Undergraduate Degree | |
Dowpharma
 Dowpharma Chemicals: SpecialtyProcess Industries Dowpharma Manufactures and distributes chemical, pharmaceutical, and biopharmaceutical products. It offers nucleic acid medicines, peptides, and ChelaMed radiopharmaceutical products. The company is headquartered in Cambridge, UK. | Chemicals: Specialty | Corporate Officer/Principal | |
Shenzhen Investment Holdings Co., Ltd.
 Shenzhen Investment Holdings Co., Ltd. Financial ConglomeratesFinance Shenzhen Investment Holdings Co., Ltd. operates as a state-owned asset management company. Its business activities include management of properties, capital operation, investment and financing, transportation logistics, manufacturing and trading, and modern service industries. The company was founded on October 13, 2004 and is headquartered in Shenzhen, China. | Financial Conglomerates | Corporate Officer/Principal | |
| Shanghai Institute of Organic Chemistry | College/University | Doctorate Degree | |
| West China Medical Center of Sichuan University | College/University | Graduate Degree | |
Jiang Xi Long Life Biopharmaceutical Co. Ltd.
 Jiang Xi Long Life Biopharmaceutical Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Chiral Quest (Suzhou) Co., Ltd., Jiang Xi Long Life Biopharmaceutical Co. Ltd. is a Chinese company that provides drug delivery services. The company is based in Nanchang, China. The company was founded by James Wu. | Miscellaneous Commercial Services | Founder | |
| Zhuhai Hengqin Yuanming Asset Management Co. Ltd. | Investment Managers | Private Equity Investor | |
Suzhou Industrial Park Bioventure Investment Management Ltd.
 Suzhou Industrial Park Bioventure Investment Management Ltd. Investment ManagersFinance Suzhou Industrial Park Bioventure Investment Management Ltd. is an Independent Venture Capital firm, a subsidiary of Ningbo Yuanyu Venture Investment Management Partnership LP founded in 2013 by Jie Chen. The Firm is headquartered in Suzhou. | Investment Managers | Private Equity Investor | |
| Qinghai Nationalities University | College/University | Undergraduate Degree | |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | Miscellaneous Commercial Services | Director/Board Member | |
Shandong Bestcomm Pharmaceutical Co., Ltd.
 Shandong Bestcomm Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shandong Bestcomm Pharmaceutical Co., Ltd. is engaged in the research, development and production of domestic pharmaceutical technology. It also offers the development of various new drugs. The company was founded on August 2, 2000 and is headquartered in Jinan, China. | Miscellaneous Commercial Services | Director/Board Member | |
Hangzhou Sciwind Biosciences Co., Ltd.
 Hangzhou Sciwind Biosciences Co., Ltd. BiotechnologyHealth Technology Hangzhou Sciwind Biosciences Co., Ltd. is a biopharmaceutical company based in Hangzhou, China. The Chinese company's product pipeline includes potentially first-in-class and drug candidates, such as the long-acting glp-1 peptide analog ecnoglutide (phase 3), oral glp-1 peptide analog xw004 (phase 1), and oral small molecule glp-1 receptor agonist xw014 (phase 1). Sciwind has developed multiple proprietary technologies, including oral peptide and inhaled protein therapeutic delivery platforms, and identified a series of drug candidates based on these core platform technologies. The company was founded in 2017 by Hai Pan, who has been the CEO since 2017. | Biotechnology | Director/Board Member | |
| Beijing Yusen Equity Investment Co. Ltd. | Investment Managers | Chairman | |
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| IDG Capital | Director/Board Member | ||
| CASI PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Hexie Zhuorui Zhuhai Investment Management Co. Ltd. | Corporate Officer/Principal |
Statistiques
Internationale
| Chine | 16 |
| Royaume-Uni | 9 |
| Etats-Unis | 4 |
| Inde | 2 |
Sectorielle
| Consumer Services | 9 |
| Health Technology | 7 |
| Finance | 6 |
| Commercial Services | 5 |
| Process Industries | 2 |
Opérationnelle
| Corporate Officer/Principal | 10 |
| Director/Board Member | 8 |
| Graduate Degree | 3 |
| Undergraduate Degree | 2 |
| Doctorate Degree | 2 |
Relations les plus connectées
| Insiders | |
|---|---|
| Xue Bo Zeng | 10 |
| Ian C. Lennon | 8 |
| Kechun Li | 8 |
| James Wu | 4 |
| Tingting Zhu | 2 |
